These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 32705261)

  • 21. Silencing of long non-coding RNA ANRIL inhibits the development of multidrug resistance in gastric cancer cells.
    Lan WG; Xu DH; Xu C; Ding CL; Ning FL; Zhou YL; Ma LB; Liu CM; Han X
    Oncol Rep; 2016 Jul; 36(1):263-70. PubMed ID: 27121324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142.
    Zhang L; Zhao G; Ji S; Yuan Q; Zhou H
    Med Sci Monit; 2020 Mar; 26():e921594. PubMed ID: 32155139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deregulation of lncRNA-AC078883.3 and microRNA-19a is involved in the development of chemoresistance to cisplatin via modulating signaling pathway of PTEN/AKT.
    Xing S; Qu Y; Li C; Huang A; Tong S; Wu C; Fan K
    J Cell Physiol; 2019 Dec; 234(12):22657-22665. PubMed ID: 31111480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The PVT1/miR-216b/Beclin-1 regulates cisplatin sensitivity of NSCLC cells via modulating autophagy and apoptosis.
    Chen L; Han X; Hu Z; Chen L
    Cancer Chemother Pharmacol; 2019 May; 83(5):921-931. PubMed ID: 30859368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.
    Pang R; Yang S
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long noncoding RNA OSER1‑AS1 promotes the malignant properties of non‑small cell lung cancer by sponging microRNA‑433‑3p and thereby increasing Smad2 expression.
    Liu X; Huang S; Guan Y; Zhang Q
    Oncol Rep; 2020 Aug; 44(2):599-610. PubMed ID: 32627026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knockdown long non-coding RNA ANRIL inhibits proliferation, migration and invasion of HepG2 cells by down-regulation of miR-191.
    Huang D; Bi C; Zhao Q; Ding X; Bian C; Wang H; Wang T; Liu H
    BMC Cancer; 2018 Sep; 18(1):919. PubMed ID: 30249208
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA ANRIL affects the sensitivity of ovarian cancer to cisplatin via regulation of let-7a/HMGA2 axis.
    Miao JT; Gao JH; Chen YQ; Chen H; Meng HY; Lou G
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31189742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA SH3PXD2A-AS1 facilitates cisplatin resistance in non-small cell lung cancer by regulating FOXM1 succinylation.
    Chen Y; Wu S; Han Y; Shi H; Yuan J; Cui W
    BMC Cancer; 2024 Jul; 24(1):848. PubMed ID: 39020302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LncRNA RP3-326I13.1 promotes cisplatin resistance in lung adenocarcinoma by binding to HSP90B and upregulating MMP13.
    Zhou H; Huang X; Shi W; Xu S; Chen J; Huang K; Wang Y
    Cell Cycle; 2022 Jul; 21(13):1391-1405. PubMed ID: 35298351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NORAD accelerates chemo-resistance of non-small-cell lung cancer via targeting at miR-129-1-3p/SOX4 axis.
    Huang Q; Xing S; Peng A; Yu Z
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894841
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long non‑coding RNA HAND2‑AS1/miR‑106a/PTEN axis re‑sensitizes cisplatin‑resistant ovarian cells to cisplatin treatment.
    Li L; Li L; Hu L; Li T; Xie D; Liu X
    Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34476500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maimendong and Qianjinweijing Tang combined with cisplatin suppressed lung cancer through targeting lncRNA-p21.
    Xie M; Wang C; Sun Y; Mao Q; Sun S; Wu M; Zhu J; Li W; Jiang Z
    J Ethnopharmacol; 2024 Mar; 322():117547. PubMed ID: 38135231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA SNHG1 contributes to cisplatin resistance in non-small cell lung cancer by regulating miR-140-5p/Wnt/β-catenin pathway.
    Shi SL; Zhang ZH
    Neoplasma; 2019 Sep; 66(5):756-765. PubMed ID: 31288529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of NEAT1 Suppresses Cell Proliferation, Migration, and Invasion in NSCLC Via Sponging miR-153-3p.
    Zhao L; Bi M; Zhang H; Shi M
    Cancer Biother Radiopharm; 2020 Jun; 35(5):362-370. PubMed ID: 32380843
    [No Abstract]   [Full Text] [Related]  

  • 36. LncRNA BLACAT1 is involved in chemoresistance of non‑small cell lung cancer cells by regulating autophagy.
    Huang FX; Chen HJ; Zheng FX; Gao ZY; Sun PF; Peng Q; Liu Y; Deng X; Huang YH; Zhao C; Miao LJ
    Int J Oncol; 2019 Jan; 54(1):339-347. PubMed ID: 30387831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
    Gao BB; Wang SX
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LINC00460 knockdown sensitizes cervical cancer to cisplatin by downregulating TGFBI.
    Tian P; Feng Y; Tao L
    Chem Biol Drug Des; 2024 Jan; 103(1):e14424. PubMed ID: 38230774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long noncoding RNA HCP5 contributes to cisplatin resistance in human triple-negative breast cancer via regulation of PTEN expression.
    Wu J; Chen H; Ye M; Wang B; Zhang Y; Sheng J; Meng T; Chen H
    Biomed Pharmacother; 2019 Jul; 115():108869. PubMed ID: 31028999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line.
    Li JH; Luo N; Zhong MZ; Xiao ZQ; Wang JX; Yao XY; Peng Y; Cao J
    Tumour Biol; 2016 Feb; 37(2):2387-94. PubMed ID: 26376998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.